Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Warning:

This document is being maintained for historical purposes, but is now out of date. To view current guidelines please visit:


1993 Sexually Transmitted Diseases Treatment Guidelines


09/24/1993

SUGGESTED CITATION
Centers for Disease Control and Prevention. 1993 Sexually
transmitted diseases treatment guidelines. MMWR 1993;42(No. RR-14):
{inclusive page numbers}.

CIO Responsible for this publication:
National Center for Prevention Services,
Division of Sexually Transmitted Diseases and HIV Prevention

Treatment
     
     In the absence of coexistent dysplasia, treatment is not
recommended for subclinical genital HPV infection diagnosed by Pap
smear, colposcopy, biopsy, acetic acid soaking of genital skin or
mucous membranes, or the detection of HPV nucleic acids (DNA or
RNA) or capsid antigen, because diagnosis often is questionable and
no therapy has been demonstrated to eradicate infection. HPV has
been demonstrated in adjacent tissue after laser treatment of
HPV-associated dysplasia and after attempts to eliminate
subclinical HPV by extensive laser vaporization of the anogenital
area of men and women.

     In the presence of coexistent dysplasia, management should be
based on the grade of dysplasia.



This page last reviewed: Monday, February 01, 2016
This information is provided as technical reference material. Please contact us at cwus@cdc.gov to request a simple text version of this document.
TOP